Patents Assigned to ARNO THERAPEUTICS, INC.
  • Methods and compositions for enhanced transungual delivery of AR-12
    Patent number: 9744156
    Abstract: Methods and compositions for enhancing transungual delivery of AR-12 comprising administering AR-12 and permeation enhancers are provided.
    Type: Grant
    Filed: August 15, 2016
    Date of Patent: August 29, 2017
    Assignee: ARNO THERAPEUTICS, INC.
    Inventors: Sathyanarayana Narasimha Murthy, Stefan Proniuk
  • Drug delivery system to increase bioavailability
    Patent number: 9579387
    Abstract: A drug delivery system is presented to increase the bioavailability of biopharmaceutic class II, III, or IV active agents.
    Type: Grant
    Filed: September 15, 2015
    Date of Patent: February 28, 2017
    Assignee: ARNO THERAPEUTICS, INC.
    Inventors: Anh Thu Thi Pham, Akaash Kumari Singh, Stefan Proniuk
  • Methods and systems for camptothecin analog synthesis
    Patent number: 9447126
    Abstract: Methods and systems for making camptothecin analogs and intermediates are provided. Aspects include safer and lower cost methodologies for making camptothecin analogs and intermediates from synthetic materials. In another aspect, the methods and systems can achieve a yield of the camptothecin analogs greater than about 0.4%.
    Type: Grant
    Filed: October 20, 2015
    Date of Patent: September 20, 2016
    Assignee: ARNO THERAPEUTICS, INC.
    Inventors: Bin-Feng Li, Ke Yuan
  • Onapristone polymorphic forms and methods of use
    Patent number: 9193757
    Abstract: Polymorphic forms of onapristone and methods of making and using such polymorphic forms are provided. Crystalline polymorphic forms can be characterized by their X-ray powder diffraction patterns and other properties.
    Type: Grant
    Filed: March 11, 2014
    Date of Patent: November 24, 2015
    Assignee: ARNO THERAPEUTICS, INC.
    Inventor: Stefan Proniuk
  • SYSTEMS AND METHODS FOR IDENTIFYING PROGESTERONE RECEPTOR SUBTYPES
    Publication number: 20150285803
    Abstract: Systems and methods for identifying progesterone positive tumors utilizing progesterone receptor isotype-specific antibodies are provided.
    Type: Application
    Filed: April 7, 2015
    Publication date: October 8, 2015
    Applicants: INVIVIS PHARMACEUTICALS INC., ARNO THERAPEUTICS, INC.
    Inventors: Erard Gilles, Alexander Zukiwski